ACOG

/Tag:ACOG

Open Letter to Doctors – A Serious Concern as Doctors Divide

TVT-O from TVT Meshed Up, UK Editorial- Jane Akre, MND - In July 2011 the U.S. Food and Drug Administration (FDA) issued a Safety Communication that surgical mesh used to treat pelvic organ prolapse (POP) carried more risks than benefits and was “of serious concern.”  See the notice Read more

By | 2014-06-03T16:20:24+00:00 June 3rd, 2014|Medical News|19 Comments

Transvaginal Mesh and $800,000 Conflicts of Interest

Dr. Vincent Lucente Mesh News Desk, March 14, 2014 ~ Some of the names in this story may sound familiar, primary among them  Dr. Vincente Lucente. He was one of the doctors mentioned during the Linda Gross transvaginal mesh trial naming manufacturer Ethicon (Johnson & Johnson). Lucente was Read more

By | 2018-07-30T13:20:43+00:00 March 14th, 2014|Media Reports|6 Comments

Highlights from AUGS Informed Consent Toolkit

  Some Highlights from the AUGS Informed Consent Toolkit, September 8-9, 2011 “At this time, AUGS does not support the routine use of transvaginal mesh for the repair of POP.” “Given the potential risks, AUGS suggest future placement of transvaginal mesh for POP repair should be judicious and be performed Read more

By | 2013-03-30T22:50:40+00:00 March 30th, 2013|Featured|0 Comments